Although ALDOA is an important oncogene in several cancer types, including non-small cell lung cancer (37), pancreatic cancer (38) and hepatocellular carcinoma (39), it is a tumor suppressor in others, including prostate adenocarcinoma and stomach adenocarcinoma (39). Here, ALDOA is linked to hepatocellular carcinoma.